Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

360616-659255

Organization: Novo Nordisk Canada Inc.
Associated registration: 954988-360616-22
Communication date: 2025-12-02
Posted date: 2026-01-15

Designated Public Office Holders who participated in the communication: Karim Bardeesy, Parliamentary Secretary to the Minister of Industry
Innovation, Science and Economic Development Canada (ISED)
 
List of Details
Subject matter Detail
Health, Research and Development, Science and Technology Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry.
Health, International Trade Free trade agreements as they relate to the biopharmaceutical industry.
Health Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.
 
Responsible Officer who filed this communication report: Vince Lamanna
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: